General Information of the Compound
Compound ID
CP0019526
Compound Name
US9221795, 27
    Show/Hide
Synonyms
GS-9901
    Show/Hide
Structure
Formula
C22H17ClFN9O
Molecular Weight
477.891
Canonical SMILES
Nc1nc(N)c(C#N)c(N[C@@H](C2CC2)c2nc3c(F)ccc(Cl)c3c(=O)n2-c2cccnc2)n1
    Show/Hide
InChI
InChI=1S/C22H17ClFN9O/c23-13-5-6-14(24)17-15(13)21(34)33(11-2-1-7-28-9-11)20(30-17)16(10-3-4-10)29-19-12(8-25)18(26)31-22(27)32-19/h1-2,5-7,9-10,16H,3-4H2,(H5,26,27,29,31,32)/t16-/m0/s1
    Show/Hide
InChIKey
XDSXYMOZKDUASY-INIZCTEOSA-N
CAS
1640247-87-5
Physicochemical Property
logP
2.96248
Rotatable Bonds
5
Heavy Atom Count
34
Polar Areas
161.42
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
10
Complexity
34

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 86763204
ChEMBL ID
CHEMBL3928407
Clinical Information about the Compound
Drug 1 ( GS-9901 )
Drug Name GS-9901
Indication
Haematological malignancy
Phase 1
Target(s)
PI3-kinase delta (PIK3CD)
Inhibitor